Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.

Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on ...

Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday ...

If you have type 2 diabetes or are considering taking a weight loss medication, keep in mind that Ozempic costs can vary greatly depending on whether or not you have health insurance coverage.

Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...

WASHINGTON (NEXSTAR) – The CEO behind the popular weight loss and diabetes drug Ozempic was in the hot seat on Capitol Hill.

In Canada, the cost of managing type 2 diabetes can vary significantly, particularly when comparing medications like Rybelsus and Ozempic, both of which contain the active ingredient semaglutide.

The company charges U.S. residents $969 a month for Ozempic, but the same drug costs $155 in Canada, $122 in Denmark, and $59 in Germany. For the weight-loss drug Wegovy, Americans pay $1,349 a month.

Senators contend the cost of the life saving drug is too high for many patients. Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and ...